C4 Therapeutics to Participate in Upcoming March Investor Conferences

Rhea-AI Summary

C4 Therapeutics, Inc. (Nasdaq: CCCC), a biopharmaceutical company innovating small-molecule medicines that degrade disease-causing proteins, has announced participation in two investor conferences in March 2021. They will present at the Cowen 41^st Annual Health Care Conference on March 3 at 11:40 a.m. ET and the Guggenheim Targeted Protein Degradation Day on March 16 at 10:30 a.m. ET. Webcasts can be accessed on their website and will be available for two weeks post-event. C4T focuses on targeted protein degradation to treat cancer, neurodegenerative diseases, and more.

WATERTOWN, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through degradation, today announced that the Company will participate in the following upcoming March investor conferences:

• Cowen 41^st Annual Health Care Conference on Wednesday, March 3, 2021 at 11:40 a.m. ET
• Guggenheim Targeted Protein Degradation Day panel discussion on Tuesday, March 16, 2021 at 10:30 a.m. ET

A live webcast of each event can be accessed under “Events & Presentations” in the Investors section of the company’s website at www.c4therapeutics.com. Replays of the webcasts will be archived on the C4T website for at least two weeks following each presentation.

About C4 Therapeutics
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases. This targeted protein degradation approach offers advantages over traditional therapies, including the potential to treat a wider range of diseases, reduce drug resistance, achieve higher potency, and decrease side effects through greater selectivity. To learn more about C4 Therapeutics, visit www.C4Therapeutics.com.

FAQ

What conferences will C4 Therapeutics participate in March 2021?

C4 Therapeutics will participate in the Cowen 41^st Annual Health Care Conference on March 3, 2021, and the Guggenheim Targeted Protein Degradation Day on March 16, 2021.

What is the time for C4T's presentation at the Cowen conference?

C4 Therapeutics will present at the Cowen 41^st Annual Health Care Conference on March 3, 2021, at 11:40 a.m. ET.

Where can I watch the C4T conference webcasts?

The webcasts for C4 Therapeutics' conference presentations can be accessed in the 'Events & Presentations' section on their website.

How long will the webcasts of C4 Therapeutics be available?

Replays of C4 Therapeutics' webcasts will be archived on their website for at least two weeks following each presentation.

What is the focus of C4 Therapeutics?

C4 Therapeutics focuses on developing novel therapeutic candidates that target and destroy disease-causing proteins, aiming to treat cancer, neurodegenerative conditions, and other diseases.